IQM, Europe’s first public quantum company, admits the future of the tech is uncertain

IQM (Finland) went public on Nasdaq Thursday via a SPAC merger at an implied valuation of ~$1.9B, but the shares spent most of the day below the IPO price, signaling a lukewarm reception. The prospectus warning that large-scale commercial traction may never occur—along with customer growth from 8 (2024) to 22 (2025)—highlights demand uncertainty until “quantum advantage” arrives. The deal is expected to generate about €198M (≈$226M) after costs, and investor enthusiasm for quantum is being supported by DOE’s plan to field a fault-tolerant, scientifically relevant quantum computer by 2028.

Analysis

The market is treating this as a financing event, not a product validation event. That matters because quantum equity value is still dominated by narrative multiples; once the listing premium fades, the stock will trade on proof of repeatable customer conversion, not headline customer counts. The biggest near-term loser is the SPAC wrapper itself: any post-close drift in RAAQ would likely be less about IQM-specific execution and more about investors re-pricing the entire quantum/SPAC bucket as a long-duration cash sink.

Second-order, this likely helps classical HPC and cloud incumbents more than the quantum ecosystem. If enterprise buyers remain in "pilot mode" for another 12-24 months, budgets stay with hybrid workflows, simulation software, and supercomputing infrastructure rather than a broad shift to quantum-native stacks. That favors names exposed to data-center capex and compute orchestration, while keeping pure-play quantum peers like QUBT vulnerable to multiple compression whenever the sector runs ahead of commercial milestones.

The policy angle is supportive but not sufficient to change fundamentals on a quarter-by-quarter basis. Government announcements can extend the runway, but they also raise the bar: once public funding is framed around a 2028 fault-tolerant target, the market will start demanding visible technical de-risking by 2026, or the stocks will lose credibility. The main reversal catalyst is not more press about sovereign support; it is evidence of larger, private-sector deals with measurable recurring revenue and service utilization.

Contrarian view: consensus may be underestimating how much sovereign sponsorship reduces financing risk, even if it does not solve demand risk. That can keep these names alive longer than skeptics expect, especially after a weak debut flushes out momentum holders. But the flip side is that this may be an attractive sell-the-rip setup rather than an outright short if float is small and policy headlines continue to create squeezes.

Key Decisions for Investors

• Avoid chasing RAAQ on the first post-merger bounce; if it trades above debut levels without a 10-Q showing accelerating backlog or deferred revenue, fade strength into the first 1-3 weeks post-listing.
• Pair trade: short RAAQ vs. long a diversified semicap/HPC proxy over the next 1-3 months. The thesis is that compute demand is real, but the monetization path is more reliable in classical infrastructure than in pre-scale quantum hardware.
• Use QUBT as the higher-beta expression for sector sentiment: only consider a tactical short on any policy-driven rally if the basket detaches from fundamental evidence; cover immediately if enterprise contract cadence or gross margin trends improve over 1-2 quarters.
• Set a watch item, not a trade, for the first public quarter after listing: if customer count growth does not translate into meaningful recurring revenue or improved revenue visibility, the sector multiple should compress by 20-30% over 6-12 months.
• Treat any DOE/sovereign contract headline as a catalyst for a short squeeze, not a thesis changer; the falsifier for a bearish stance is a material increase in private-sector bookings and a clear path to repeatable cloud consumption by year-end.